Title:
【発明の名称】ベンゾキサジノンHIV逆転写酵素阻害剤の経口液体調合物
Document Type and Number:
Japanese Patent JP2002502878
Kind Code:
A
Abstract:
A palatable oral liquid pharmaceutical composition of benzoxazinone compounds useful as HIV reverse transcriptase inhibitors comprising the benzoxazinone active ingredient in a liquid vehicle comprising medium chain fatty acid triglycerides. Other formulating agents such as sweetening agents, lecithin suspending agents, etc. may be optionally added.
Inventors:
Bahar Shrendra Em.
Morin Michael Bee.
Morin Michael Bee.
Application Number:
JP2000531173A
Publication Date:
January 29, 2002
Filing Date:
February 17, 1999
Export Citation:
Assignee:
DuPont Pharmaceuticals Company
International Classes:
A61K9/107; A61K9/00; A61K9/48; A61K31/538; A61K47/14; A61P31/18; A61P37/04; (IPC1-7): A61K31/538; A61K9/107; A61K9/48; A61K47/14; A61P31/18; A61P37/04
Attorney, Agent or Firm:
Yoshikazu Tani (2 outside)